By Josh White
Date: Monday 26 Feb 2024
(Sharecast News) - Infection prevention products developer Tristel announced the successful conclusion of all reviews required under the UK and European Union medical devices regulations for the approval of its TANK ClO2 sporicidal disinfectant system on Monday.
Tristel flags record first half, CEO to step down | 19-Dec-2023 | ShareCast |
Tristel profits jump as US sales kick off | 16-Oct-2023 | ShareCast |
Director dealings: Tristel non-exec buys first s... | 26-Jun-2023 | ShareCast |
Broker tips: Fevertree,Tristel | 25-May-2023 | ShareCast |
Numis starts coverage of Tristel at 'add' | 25-May-2023 | ShareCast |
Director/PDMR Shareholding | 16-Apr-2024 | 14:04 | RNS |
Exercise of Share Options and Total Voting Rights | 15-Apr-2024 | 17:56 | RNS |
Exercise of Share Options and Total Voting Rights | 19-Mar-2024 | 09:25 | RNS |
Exercise of Share Options and Total Voting Rights | 27-Feb-2024 | 07:00 | RNS |
Half-year Report | 26-Feb-2024 | 07:01 | RNS |
Cash planted into TEG | 11-Nov-2007 | Scotland on Sunday |
Space at a premium | 05-Nov-2006 | Scotland on Sunday |
Strong showing from metals and oil lifts Footsie | 30-Oct-2007 | Guardian |
Small caps | 30-Oct-2007 | Times |
Commodity shares lead the way | 09-Jul-2007 | Guardian |
Mortgage banks and housebuilders knock Footsie | 28-Jun-2007 | Guardian |
Commodities outlook buoys Anglo American | 20-Feb-2007 | Guardian |
No recent information was found.
Currency | UK Pounds |
Share Price | 480.00p |
Change Today | 15.00p |
% Change | 3.23 % |
52 Week High | 485.00 |
52 Week Low | 327.50 |
Volume | 33,518 |
Shares Issued | 47.52m |
Market Cap | £228.12m |
RiskGrade | 180 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 21-Mar-24 | 23-Nov-23 |
Paid | 12-Apr-24 | 22-Dec-23 |
Amount | 5.24p | 7.88p |
Time | Volume / Share Price |
16:35 | 1 @ 480.00p |
16:35 | 2 @ 460.00p |
16:35 | 18 @ 480.00p |
16:35 | 7 @ 480.00p |
16:35 | 7 @ 480.00p |
CEO | Paul Christopher Swinney |
Finance Director | Elizabeth Dixon |
You are here: research